Combination therapy shows promising efficacy in aggressive leukemia

Acute myeloid leukemia (AML) is a particularly aggressive form of blood cancer that usually progresses rapidly if swift and intensive treatment is not applied. Although the disease can often be contained by chemotherapy (remission), it returns in many patients. A permanent cure is often only possible with a stem cell transplant—provided that the leukemia can be sufficiently contained beforehand.